Organic & Biomolecular Chemistry
Paper
formed using silica gel 60 GF254 pre-coated aluminum backed
plates (2.5 mm). Visualization was accomplished by examin-
Conflicts of interest
ation under UV light at 254 nm and/or ninhydrin stain. There are no conflicts to declare.
Column chromatography was performed using silica gel
(200–300 mesh) eluting with petroleum ether and ethyl
acetate. NMR spectra were recorded with tetramethylsilane as
1
Acknowledgements
internal standard. H NMR spectra were recorded at 400 MHz,
and 13C NMR spectra were recorded at 100 MHz (Bruker and
R. G. B. thanks DST-SERB (EMR/2015/000909), Govt. of India
for a generous research grant. T. M. K. and A. D. S. thank
CSIR, New Delhi for fellowship. P. K. W. thanks UGC, New
Delhi for a fellowship. The authors thank IISER Pune for finan-
cial assistance.
Jeol). Chemical shifts (δ) are reported in ppm downfield from
CDCl3 (δ = 7.26 ppm) and CD3OD (δ = 4.87 and 3.31 ppm) for
1H NMR and relative to the central CDCl3 resonance (δ =
77.16 ppm) and CD3OD (δ = 49.00) for 13C NMR spectroscopy.
Coupling constants (J) are given in Hz. IR spectra were
obtained using a FT-IR spectrophotometer as neat and are
reported in cm−1. Samples were analyzed by high-resolution
mass spectrometry using ESI TOF.
Notes and references
General procedure for the synthesis of 3-substituted
pyroglutamic acid derivative 4
1 (a) J. W. Ferkany, R. Zaczek and J. T. Coyle, Nature, 1982,
298, 757–759; (b) L. Qiao, S. Wang, C. George, N. E. Lewin,
P. M. Blumberg and A. P. Kozikowski, J. Am. Chem. Soc.,
1998, 120, 6629–6630; (c) M. Anwar, J. H. Bailey,
L. C. Dickinson, H. J. Edwards, R. Goswami and
M. G. Moloney, Org. Biomol. Chem., 2003, 1, 2364–2376;
(d) T. A. M. Gulder and B. S. Moore, Angew. Chem., Int. Ed.,
2010, 49, 9346–9367; (e) M. Oikawa, S. Sasaki, M. Sakai,
Y. Ishikawa and R. Sakai, Eur. J. Org. Chem., 2012, 5789–
5802; (f) D. B. Liss, M. S. Paden, E. S. Schwarz and
M. E. Mullins, Clin. Toxicol., 2013, 51, 817–827.
2 (a) J. Gante, Angew. Chem., Int. Ed. Engl., 1994, 33, 1699–
1720; (b) J. Vagner, H. Qu and V. J. Hruby, Curr. Opin.
Chem. Biol., 2008, 12, 292–296; (c) V. Toum, J. Bolley,
Y. Lalatonne, C. Barbey, L. Motte, M. Lecouvey, J. Royer,
N. Dupont and J. Pérard-Viret, Eur. J. Med. Chem., 2015, 93,
360–372.
3 (a) O. Goldberg, A. Luini and V. I. Teichberg, J. Med. Chem.,
1983, 26, 39–42; (b) M. G. Moloney, Nat. Prod. Rep., 2002,
19, 597–616; (c) A. J. Meade, B. P. Meloni, F. L. Mastaglia,
P. M. Watt and N. W. Knuckey, Brain Res., 2010, 1360, 8–16.
4 (a) G. C. B. Harriman, Tetrahedron Lett., 1997, 38, 5591–
5594; (b) C. Hanusch-Kompa and I. Ugi, Tetrahedron Lett.,
1998, 39, 2725–2728; (c) H. Tye and M. Whittaker, Org.
Biomol. Chem., 2004, 2, 813–815; (d) C. B. Gilley,
M. J. Buller and Y. Kobayashi, Org. Lett., 2007, 9, 3631–
3634; (e) N. Isambert, M. Cruz, M. J. Arévalo, E. Gómez and
R. Lavilla, Org. Lett., 2007, 9, 4199–4202; (f) J. Isaacson and
Y. Kobayashi, Angew. Chem., Int. Ed., 2009, 48, 1845–1848;
(g) C. Huo and Y. Yuan, J. Org. Chem., 2015, 80, 12704–
12710.
In an oven-dried 10 mL round bottom flask with a Teflon-
coated stir bar, Meldrum’s acid 1 (200 mg, 1.39 mmol,
1 equiv.) was dissolved in 6 mL of EtOAc. Then benzaldehyde
2a (150 µL, 1.47 mmol, 1.06 equiv.) and Schiff’s base 3a
(532.9 mg, 1.8 mmol, 1.3 equiv.) were added and the reaction
mixture was stirred for 24 h at rt. On completion of the reac-
tion (monitored by TLC), the reaction mixture was directly
transferred in to a separating funnel and portioned between
saturated aq. NaHCO3 solution (25 mL) and EtOAc (20 mL).
The aqueous layer containing pyroglutamic acid derivative 4a′
was separated and the bicarbonate extraction repeated twice.
The combined aqueous layers were acidified with 1 N aq. HCl
solution till solution became turbid (pH ∼2). After which, the
pyroglutamic acid derivative 4a′ was then back-extracted with
EtOAc (3 × 20 mL) and the combined organic layers were
washed with brine and dried over anhydrous Na2SO4. The
organic extract was evaporated under vacuum to afford 4a′.
The crude pyroglutamic acid derivative 4a′ was dissolved in
2 mL toluene and refluxed for 6 h in order to effect complete
decarboxylation (monitored by TLC). Toluene was then
evaporated and the crude product 4a purified by column
chromatography on silica gel using petroleum ether/ethyl
acetate as eluent. Product 4a was obtained as a white solid in
65% yield.
trans-tert-Butyl 5-oxo-3-phenylpyrrolidine-2-carboxylate (4a).
Compound 4a was synthesized following the general procedure
and was obtained as white solid (235 mg, 65% trans/cis; 3.6 : 1,
after recrystallization from DCM/n-hexane solvent system trans/
cis 20 : 1).
M.p. 110–112 °C. 1H NMR (400 MHz, CDCl3) δ 7.38–7.34
(m, 2H), 7.30–7.26 (m, 3H), 6.31 (s, 1H), 4.15 (d, J = 6.0 Hz,
1H), 3.68–3.63 (m, 1H), 2.85 (dd, J = 17.3, 9.5 Hz, 1H), 2.54 (dd,
J = 17.3, 7.4 Hz, 1H), 1.43 (s, 9H). 13C NMR (100 MHz, CDCl3)
δ 176.5, 170.3, 141.9, 129.1, 127.6, 127.2, 82.8, 63.6, 44.4, 38.4,
28.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C15H20NO3
262.1443, found 262.1450. FTIR cm−1 (neat) 3233, 2978, 2927,
1702, 1453, 1370, 1236, 1154, 845.
5 (a) A. R. Mohite and R. G. Bhat, Org. Lett., 2013, 15, 4564–
4567; (b) A. R. Mohite, T. B. Mete and R. G. Bhat,
Tetrahedron Lett., 2017, 58, 770–774.
6 (a) A. M. Dumas and E. Fillion, Acc. Chem. Res., 2010, 43,
440–454; (b) E. Pair, T. Cadart, V. Levacher and J.-F. Brière,
ChemCatChem, 2016, 8, 1882–1890.
7 (a) T. Tsubogo, S. Saito, K. Seki, Y. Yamashita and
S. Kobayashi, J. Am. Chem. Soc., 2008, 130, 13321–13332;
This journal is © The Royal Society of Chemistry 2019
Org. Biomol. Chem., 2019, 17, 561–566 | 565